| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2007 | CA2643803A1 .beta. crystalline form of perindopril arginine salt, method for making same, and pharmaceutical compositions containing same |
| 09/07/2007 | CA2643714A1 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 09/07/2007 | CA2643579A1 Benzochromenone derivatives useful as anti-angiogenesis and anti-cancer agents |
| 09/07/2007 | CA2643559A1 Antiviral drugs for treatment of arenavirus infection |
| 09/07/2007 | CA2643492A1 Nanoparticulate carvedilol formulations |
| 09/07/2007 | CA2643360A1 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 09/07/2007 | CA2643320A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2643282A1 Compositions and methods for effecting controlled posterior vitreous detachment |
| 09/07/2007 | CA2643238A1 Improved antitumoral treatments |
| 09/07/2007 | CA2643111A1 Targeted delivery of pharmaceutical compounds |
| 09/07/2007 | CA2643100A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | CA2643038A1 Hexose compounds to treat cancer |
| 09/07/2007 | CA2643037A1 Compositions and methods for delivery of amino-functional drugs |
| 09/07/2007 | CA2643030A1 Epinephrine dosing regimens |
| 09/07/2007 | CA2643021A1 Imidazole-based compounds, compositions comprising them and methods of their use |
| 09/07/2007 | CA2642973A1 Quinoline derivatives |
| 09/07/2007 | CA2642969A1 Method for increasing lean musclse mass and decreasing adipose tissue |
| 09/07/2007 | CA2642943A1 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs |
| 09/07/2007 | CA2642931A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives |
| 09/07/2007 | CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | CA2642813A1 Inhibitors of histone deacetylase |
| 09/07/2007 | CA2642662A1 Compounds for the treatment of metabolic disorders |
| 09/07/2007 | CA2642649A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2642598A1 Selective androgen receptor modulators |
| 09/07/2007 | CA2642424A1 Primary amines as renin inhibitors |
| 09/07/2007 | CA2642368A1 Treatment of prevention of valvular heart disease with flibanserin |
| 09/07/2007 | CA2642195A1 Fluvastatin sodium pharmaceutical compositions |
| 09/07/2007 | CA2642189A1 Mannose derivatives for killing tumor cells |
| 09/07/2007 | CA2642180A1 Fluvastatin sodium novel forms and preparation therof |
| 09/07/2007 | CA2641781A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 09/07/2007 | CA2641624A1 Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor ligands |
| 09/07/2007 | CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/07/2007 | CA2641160A1 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 09/07/2007 | CA2641145A1 Sigma receptor compounds |
| 09/07/2007 | CA2641144A1 Pyrazole derivatives as sigma receptor inhibitors |
| 09/07/2007 | CA2640757A1 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 09/07/2007 | CA2640754A1 Pyrazole derivatives as sigma receptors antagonists |
| 09/07/2007 | CA2640753A1 Sigma receptor inhibitors |
| 09/07/2007 | CA2640738A1 Hydroxylamines and derivatives for the inhibition of complement activation |
| 09/07/2007 | CA2640575A1 Compositions and methods for inducing bone growth and inhibiting bone loss |
| 09/07/2007 | CA2638797A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | CA2638768A1 Antimicrobial releasing polymers |
| 09/07/2007 | CA2638734A1 Inhibitors of the unfolded protein response and methods for their use |
| 09/07/2007 | CA2636431A1 Steroidal compounds as steroid sulphatase inhibitors |
| 09/07/2007 | CA2635280A1 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 09/07/2007 | CA2633803A1 Soft protease inhibitors and pro-soft forms thereof |
| 09/07/2007 | CA2633464A1 Compositions and methods for dermal delivery of drugs |
| 09/07/2007 | CA2633069A1 New 3'-, 7-substituted indirubins and their applications |
| 09/07/2007 | CA2628964A1 Formulations of fispemifene |
| 09/07/2007 | CA2614639A1 Pharmaceutical composition for treatment of blood clotting disorder |
| 09/07/2007 | CA2611577A1 Antibiotic kit and composition and uses thereof |
| 09/06/2007 | US20070209082 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 09/06/2007 | US20070208347 Spine distraction implant and method |
| 09/06/2007 | US20070208185 Intermediates for the hemisynthesis of taxanes and preparation processes therefor |
| 09/06/2007 | US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 09/06/2007 | US20070208176 Biphenyl derivatives |
| 09/06/2007 | US20070208167 Compounds and methods for modulating activation of NF-kappaB |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208087 Compounds, compositions and methods for the treatment of inflammatory diseases |
| 09/06/2007 | US20070208086 Ubiquinone analogs and methods of use |
| 09/06/2007 | US20070208085 Potent cytotoxicity and inhibition of pan-cell cycle progression by an alkylating anthraquinone |
| 09/06/2007 | US20070208084 Enantiomers of O-desmethyl venlafaxine |
| 09/06/2007 | US20070208083 para-methyl-trans-N-(4-hydroxy-3-methoxy-benzyl)-cinnamic acid amide in the form of pure isomer; reacting para-tert.-butylbenzaldehyde in presence of piperidine base with malonic acid to form para-alkyl substituted cinnnamic acid, reacting intermeidate with 4-hydroxy-3-methoxybenzylamine; analgesic |
| 09/06/2007 | US20070208082 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
| 09/06/2007 | US20070208081 Oligomeric Compounds |
| 09/06/2007 | US20070208080 1-(4-t-butylbenzyl)-3-(3-fluoro-4-methanesulfonylaminobenzyl)thiourea |
| 09/06/2007 | US20070208079 Inhibitors of nuclear factor kappa B (NF- kappa B) and inhibit the activity of the endothelin receptor; inhibit cell proliferation and for the induction of apoptosis |
| 09/06/2007 | US20070208078 Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient |
| 09/06/2007 | US20070208077 Adiponectin Enhancer |
| 09/06/2007 | US20070208076 Injectable chemotherapeutic solution of Erythrosin B, Phloxine B, Rose Bengal, 4,5,6,7-Tetrabromoerythrosin or their salts in a hydrophilic vehicle containing sodium, potassium, calcium or magnesium chloride, phosphate, or nitrate; low levels of pyrogens and particles |
| 09/06/2007 | US20070208075 Pharmaceutical compositions |
| 09/06/2007 | US20070208074 Methods and compositions for treating and preventing tumors |
| 09/06/2007 | US20070208073 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 09/06/2007 | US20070208072 Maleate salt of tegaserod and crystalline forms thereof |
| 09/06/2007 | US20070208071 Oxidative Degradation Products of Atorvastatin Calcium |
| 09/06/2007 | US20070208070 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/06/2007 | US20070208069 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/06/2007 | US20070208068 Aqueous Composition Comprising Thiazole Derivative |
| 09/06/2007 | US20070208067 Tablet Formulations and Processes |
| 09/06/2007 | US20070208066 ER-beta-selective ligands |
| 09/06/2007 | US20070208065 Such as 5-[4-(1,1-dimethylethyl)phenyl]-N-hydroxy-4-phenyl-2-oxazolchexanamide which inhibits production of IL-6 and/or TNF alpha by inflammatory cytokines; inflammatory diseases, autoimmune diseases |
| 09/06/2007 | US20070208064 Ion channel modulators |
| 09/06/2007 | US20070208063 Imidazole-based compounds, compositions comprising them and methods of their use |
| 09/06/2007 | US20070208062 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections |
| 09/06/2007 | US20070208061 N-(1-(5-(2-(1H-indol-3-yl)ethyl)-4-(2,4-dimethoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)-2-amino-2-methylpropanamide; useful for treating growth retardation, cachexia, obesity, food intake, energy balance, tumor cell proliferation, wound/burn healing, metabolic disorders and inflammation. |
| 09/06/2007 | US20070208060 Compounds for treating inflammatory diseases |
| 09/06/2007 | US20070208059 Therapeutic Agents |
| 09/06/2007 | US20070208058 Stable Pharmaceutical Compositions and Methods of Making and Using Same |
| 09/06/2007 | US20070208057 Methods And Compositions Using Thalidomide For The Treatment And Management Of Cancers And Other Diseases |
| 09/06/2007 | US20070208056 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 09/06/2007 | US20070208055 Alternative synthesis of renin inhibitors and intermediates thereof |
| 09/06/2007 | US20070208054 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 09/06/2007 | US20070208053 Fused heterobicyclic kinase inhibitors |
| 09/06/2007 | US20070208052 Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| 09/06/2007 | US20070208051 Novel N-(Alkoxyalkyl) Carbamoyl-Substituted 6-Phenyl-Benzonaphthyridine Derivatives and their Use as Pde 3/4 Inhibitors |
| 09/06/2007 | US20070208050 Process for preparing irinotecan |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208047 administering Elvucitabine for treatment of hepatitis B and/or human immunodeficiency virus |